Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-05

Clinical Trial Update: Short Term Effects of a Hibiscus Sabdariffa and Stevia Rebaudiana Drink on Cardiac Relaxation and Urinary Albumin Excretion in a Group of Diabetic Type 2 Subjects [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating short-term effects of a Hibiscus sabdariffa and Stevia rebaudiana drink on cardiac relaxation and urinary albumin excretion in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Yaounde Central Hospital | Conditions: Benefits of a Hibiscus Sabdariffa and Stevia Rebaudiana Drink in Patients With Type 2 Diabetes Mellitus Before and After 8 Weeks of add-on Therapy | Phase 4 | Status: COMPLETED